What the Patient Considers When Choosing a Laboratory - Insights

Patients want to use a laboratory that is easy to work with, and there are different definitions of “easy.” Ultimately, health systems want to have the patients they serve use their health system laboratories. If patients are choosing to go...

How to Create a Positive Customer Experience - Insights

In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, talks with outreach solutions strategists Ellen Dijkman Dulkes and Brianne Newton about...

Marketing Strategies and Considerations for the Outreach Laboratory - Insights

In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, talks with Andrew Tofilon, director of marketing at Mayo Clinic Laboratories. They discuss...

Maintaining Quality Within an Outreach Program - Insights

In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, talks with quality management coordinator Kate Pearce about optimizing preanalytic quality...

Mayo Clinic Laboratory and pathology research roundup: January 10 - Insights

This week's research roundup features: Drug testing in support of the diagnosis of neonatal abstinence syndrome: The current situation

Hepatocellular Carcinoma Risk Panel with GALAD Score - Insights

In this “Hot Topic,” Joshua Bornhorst, Ph.D., assistant professor of laboratory medicine and pathology at Mayo Clinic, reviews biomarker component testing for hepatocellular carcinoma, explains the GALAD score, and explores GALAD score...

Predictors to Direct Neural Antibody Testing in Autoimmune Encephalitis/Epilepsy - Insights

In this “Hot Topic,” Divyanshu Dubey, M.B.B.S., associate professor of laboratory medicine and pathology and neurology at Mayo Clinic, discusses various clinical and paraclinical features of autoimmune encephalitis, autoimmune seizures, and...

Mayo Clinic Labs @Work: Kimberly Knight - Insights

As a national accounts executive for Mayo Clinic Laboratories, Kimberly Knight helps clients see and understand the importance of laboratory testing and how partnering with Mayo Clinic Laboratories on that testing can help them and their...

Mayo Clinic Labs @Work: Callie Bishop - Insights

As a director of operations for Mayo Clinic Laboratories, Callie Bishop helps meet the needs of Mayo Clinic Laboratories clients both virtually and onsite in the field.

Mayo Clinic Labs @Work: Paul Schneider - Insights

As a national accounts executive for Mayo Clinic Laboratories, Paul Schneider helps to improve and advance diagnostic patient care by bringing Mayo Clinic Laboratories testing to many of the nation’s top health care systems.

Lab Week: Appreciating clinical laboratory personnel - Insights

Thank you to all laboratory professionals for their efforts to provide critical answers for patients every day, and drive innovation in the field of medicine.

Malabsorption panel: Filling a gap in pediatric care - Insights

Mayo Clinic Laboratories is committed to innovation that provides the right test at the right time for the right patients. That effort always starts with identifying gaps in patient care. Filling those gaps sometimes involves not developing...

Identifying disease biomarkers with phage immunoprecipitation sequencing - Insights

Mayo Clinic’s Advanced Diagnostics Laboratory researchers are using phage immunoprecipitation sequencing to discover new serological biomarkers for autoimmune diseases.

Noninvasive DNA testing via liquid biopsy - Insights

The MayoComplete Liquid Biopsy Panel offers a noninvasive alternative to traditional cell-based biopsies. This allow for faster turnaround time and the ability to perform molecular DNA testing in cancer patients where tumor tissue isn’t...

Emerging fungal pathogens: Dr. Nancy Wengenack - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and Nancy Wengenack, Ph.D., director of the Mycology and Mycobacteriology Laboratories at Mayo...

How digital pathology provides faster answers - Insights

Almost four years ago, Mayo Clinic launched the Digital Pathology Program, a major pathology initiative. Phase 2 of this multi-phase rollout has recently been completed, which involved the implementation of cutting-edge digital equipment...

Unique collaboration advances discoveries for rare disease - Insights

The nonprofit patient advocacy group called The MOG Project supports patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), which is a rare and debilitating central nervous system demyelinating disorder. A...

Melanoma panel expands ability to diagnose tumors - Insights

Mayo Clinic Laboratories’ MayoComplete Melanoma Panel is a comprehensive test that better informs the prognosis and treatment of melanoma. It can be applied to unusual tumors that haven’t yet been identified as melanoma as well as melanomas...

Expanded colorectal cancer panel tests more genes - Insights

Mayo Clinic Laboratories has developed a new colorectal cancer test, the MayoComplete Colorectal Cancer Panel (Mayo ID: MCCRC), in response to the latest recommendations for testing and treatment from the American Society of Clinical...

The Latest on Measles: Matthew Binnicker, Ph.D. - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory at Mayo...

Key performance indicators for laboratory outreach programs - Insights

Key performance indicators (KPIs) should be a part of every laboratory’s quality improvement plan, and that includes outreach-specific KPI metrics. Financial, internal-facing, and client-facing KPIs for outreach programs help to create a...

Domestic Logistics Impacts: Independence Day Holiday Weekend - Insights

Due to the upcoming Independence Day holiday on Tuesday, July 4, Mayo Clinic Laboratories' sample pickup and delivery schedules will be altered. To ensure sample viability and minimize test turnaround time delays, we have implemented...

Memorial Day Specimen Shipment Alert - Insights

Due to the Memorial Day holiday (recognized on Monday, May 29), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and turnaround times are not affected, please plan...

Making sense of an ever-changing regulatory environment - Insights

In this episode of Mayo Clinic Laboratories “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, and Shannon Bennett, director of regulatory affairs for Mayo Clinic’s Department of...

New AI-augmented test refines kidney stone analysis - Insights

Since March 2019, Paul Jannetto, Ph.D., director of the Metals Laboratory at Mayo Clinic, along with his colleagues across the enterprise and his laboratory staff, have developed, validated, and implemented an artificial intelligence...

Collaboration identifies previously unknown blood clotting condition - Insights

A medical mystery surrounding a clotting disease spurred a collaboration between Mayo Clinic and University of Michigan Health to develop a new test methodology and the discovery of a previously unknown blood clotting condition.

Register Now: 24th International Surgical Pathology Symposium - Insights

The 24th International Surgical Pathology Symposium is an exciting opportunity for practicing surgical pathologists to expand their knowledge and skills. Presented by Mayo Clinic Laboratories, this four-day conference will address common...

Mayo Clinic Labs @Work: Vanessa Gonzalez Casar - Insights

As a hospital account executive for Mayo Clinic Laboratories, Vanessa Gonzalez Casar supports and partners with local hospitals to ensure their patients receive the right test at the right time.

Legislative update and at-home testing: Dr. Bill Morice - Insights

William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, they kick off the new year with a...

Chromosomal microarray better informs brain tumor diagnosis - Insights

Molecular biomarkers are a critical component in the treatment of adult and pediatric brain tumors. Robert Jenkins, M.D., Ph.D., explains how Mayo Clinic Laboratories' chromosomal microarray provides more comprehensive and accurate tumor...

West Nile virus: Elitza Theel, Ph.D. - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic,...

Neurofilament light chain: Bjorn Oskarsson, M.D. - Insights

In this test-specific episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and Bjorn Oskarsson, M.D., a neurologist at Mayo Clinic’s Florida campus, discuss...

Ethanol biomarker test features longer detection window - Insights

Mayo Clinic Laboratories has developed a new direct ethanol biomarker test for alcohol consumption that has a much longer detection window than existing urine tests for alcohol use.

A novel testing approach for newly identified VEXAS syndrome - Insights

VEXAS syndrome is a severe autoinflammatory disease that results in a spectrum of rheumatologic and hematologic conditions. The underlying cause of newly identified VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome —...

Mayo Clinic monitoring rising avian influenza cases - Insights

In a post on Mayo Clinic’s News Network, Mayo Clinic’s director of Clinical Virology, Matthew Binnicker, Ph.D., explains the concern over a potential human-to-human outbreak of avian influenza and what’s being done at Mayo Clinic and...

Flea-borne Typhus: Elitza Theel, Ph.D. - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at...

What to Know About Leprosy: Nancy Wengenack, Ph.D. - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Nancy Wengenack, Ph.D., director of the Mycology and Mycobacteriology Laboratories...

Dengue and Chikungunya Outbreaks: Elitza Theel, Ph.D. - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic,...

Why cancer death rates are declining: Dr. Ansell - Insights

Steven Ansell, M.D., Ph.D., chair of the Division of Hematology and senior deputy director, Midwest, Mayo Clinic Comprehensive Cancer Center, joins the "Answers From the Lab" podcast for a discussion with host Bobbi Pritt, M.D., about...

The Importance of Sales Call Planning in Laboratory Outreach Sales - Insights

Sales is a vital component of a thriving laboratory outreach program. It requires a unique skill set and a dedicated focus on advocating the value of your laboratory and its ability to deliver reliable, high-quality services to your...

Driving Change and Growth Through the Laboratory Sales Team - Insights

In this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, talks with vice president of sales and services John Heywood about the important role of...

Synthesizing cardiovascular genetic test results into a unified diagnosis for the patient - Insights

For over two decades, Mayo Clinic has been at the forefront of cardiovascular (CV) genetic testing. The current test menu features 24 different panels that span over 300 genes linked to inherited cardiovascular disorders, many of which are...

Regaining quality of life after a decade lost to misdiagnosis: Kelly Dubois - Insights

Misdiagnosed with acromegaly, a disease marked by too much growth hormone, and plagued by a host of mysterious health problems from unnecessary medications, Kelly DuBois finally found answers after pharmacogenomic testing from Mayo Clinic...

Reclaiming strength and independence after rare cancer diagnosis: Alexa Lofaro - Insights

It’s been more than three years since a team of specialists and genetic testing by Mayo Clinic Laboratories helped pinpoint the cause of Alexa Lofaro’s failing health. And today, she says she continues to feel “so much better” than she did...

COVID-19: The pandemic that's forever changed laboratory testing - Insights

Since March 2020, the COVID-19 pandemic has had a lasting impact on the lives of millions of people around the world, including the many brave health care workers who risked their own health to provide lifesaving care to those infected by...

Lab discoveries fuel updates for autoimmune movement disorders test - Insights

Mayo Clinic Laboratories expanded movement disorders panel better identifies autoimmune conditions. Four recently identified biomarkers — septin-5, septin-7, neurochondrin, and adaptor protein-3B2 — have been added to the panel, and all...

Progressive alliance advances science through patient-powered research - Insights

Tying together the expertise and curiosity of Mayo Clinic autoimmune neurology researchers with eager patients who have rare disease and are looking for answers, the innovative collaboration benefits both patients affected by MOGAD and...

Diagnostic expertise leads to recovery from rare cancer: Alison O'Neill - Insights

After what looked like a blemish turned out to be angiosarcoma, a rare, life-threatening cancer of the blood vessels, Alison O'Neill was put on an aggressive treatment plan and regenerative approach to healing made possible by the...

Artificial intelligence paves way for earlier detection of gastrointestinal cancers - Insights

Mayo Clinic researchers are now using artificial intelligence (AI) systems to help increase polyp detection during colonoscopies and identify colorectal cancer at an early stage. Like facial recognition software that recognizes faces, this...

Seasonal Outlook of Respiratory Viruses: Matthew Binnicker, Ph.D. - Insights

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, is joined by Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory at Mayo...